1 |
-aminosalicylic acid |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [2] 96, 97 💬 |
2 |
0,25 mg rpc1063 |
- |
- |
- |
- |
096 [1] 96 💬 |
3 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
4 |
0114-0006b |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
5 |
10 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
6 |
10% metronidazole ointment |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 [1] 96 💬 |
7 |
1000 iu d3 |
- |
- |
- |
- |
096 [1] 96 💬 |
8 |
13-valent pneumococcal conjugated vaccine (pcv13) |
- |
- |
- |
- |
096 [1] 96 💬 |
9 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 [12] 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
10 |
1mg rpc1063 |
- |
- |
- |
- |
096 [1] 96 💬 |
11 |
2'-fucosyllactose |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
12 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 [1] 96 💬 |
13 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
14 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
15 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
096 [2] 96, 97 💬 |
16 |
331731-18-1 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
17 |
4-aminosalicylic acid |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [1] 96 💬 |
18 |
4-aminosalicylic acid extended release granules |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [1] 96 💬 |
19 |
40 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
20 |
40 mg msb11022 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
21 |
42942019 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
22 |
5-aminolevulinic acid |
Aminolevulinic acid |
[2] D02908 D02908, D07567 D07567 💬 |
- |
- |
096 [1] 96 💬 |
23 |
5-aminosalicyl acid |
- |
- |
- |
- |
096 [1] 96 💬 |
24 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
25 |
5-aminosalicylic acid |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
26 |
5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
27 |
5-htp |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
28 |
5000 iu d3 |
- |
- |
- |
- |
096 [1] 96 💬 |
29 |
549-0261/f02-01 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
30 |
6 mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
31 |
6-[(methyl-4-nitro-1h-imidazol-5-yl)thio]-1h-purine |
- |
- |
- |
- |
096 [1] 96 💬 |
32 |
6-mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [3] 96, 97, 164 💬 |
33 |
6-mercaptopurine (puri-nethol) |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [1] 96 💬 |
34 |
6-mp |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
35 |
683699 |
- |
- |
- |
- |
096 [1] 96 💬 |
36 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
37 |
80 mg dr-6mp |
- |
- |
- |
- |
096 [1] 96 💬 |
38 |
99mtc-s-hynic certolizumab pegol |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 96 💬 |
39 |
?-3 polyunsaturated fatty acid |
- |
- |
- |
- |
096 [1] 96 💬 |
40 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
41 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
42 |
[18f]fspg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
43 |
[cx601] |
- |
- |
- |
- |
096 [1] 96 💬 |
44 |
[ops-2071] |
- |
- |
- |
- |
096 [1] 96 💬 |
45 |
[rpc0163] |
- |
- |
- |
- |
096 [1] 96 💬 |
46 |
[rpc1063] |
- |
- |
- |
- |
096 [1] 96 💬 |
47 |
A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine |
Clarithromycin |
[3] D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 [1] 96 💬 |
48 |
A-1293543.74 |
- |
- |
- |
- |
096 [1] 96 💬 |
49 |
Ab1010 |
- |
- |
- |
- |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
50 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
51 |
Abbv-066 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
52 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
53 |
Abrilumab |
Abrilumab |
[1] D10540 D10540 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
54 |
Abt 494 12mg |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
55 |
Abt 494 3mg |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
56 |
Abt humira |
- |
- |
- |
- |
096 [1] 96 💬 |
57 |
Abt-494 |
- |
- |
- |
- |
041 [6] 41, 46, 49, 96, 97, 271 💬 |
58 |
Abt-874 |
- |
- |
- |
- |
096 [1] 96 💬 |
59 |
Abx464 |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
60 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
61 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
62 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
63 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
64 |
Adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
65 |
Adalimumab (40 mg) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
66 |
Adalimumab (d2e7) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 271 💬 |
67 |
Adalimumab 40 mg eow or ew |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
68 |
Adalimumab and infliximab |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
69 |
Adalimumab injection |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 96 💬 |
70 |
Adalimumab prn |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
71 |
Adsvf |
- |
- |
- |
- |
096 [1] 96 💬 |
72 |
Adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
085 [2] 85, 96 💬 |
73 |
Agri-king synbiotic (aksb) |
- |
- |
- |
- |
096 [1] 96 💬 |
74 |
Ain457 |
- |
- |
- |
- |
013 [7] 13, 37, 41, 46, 56, 96, 271 💬 |
75 |
Albendazole |
Albendazole |
[1] D00134 D00134 💬 |
- |
- |
096 [1] 96 💬 |
76 |
Albendazole (eskazole) |
Albendazole |
[1] D00134 D00134 💬 |
- |
- |
096 [1] 96 💬 |
77 |
Albumen |
Egg white |
- |
- |
- |
096 [1] 96 💬 |
78 |
Albumine humaine |
- |
- |
- |
- |
096 [1] 96 💬 |
79 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
80 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
81 |
Alequel |
- |
- |
- |
- |
096 [1] 96 💬 |
82 |
Alfacalcidol |
Alfacalcidol |
[1] D01518 D01518 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 [6] 41, 46, 49, 50, 96, 235 💬 |
83 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 [2] 96, 97 💬 |
84 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 [1] 96 💬 |
85 |
Allo-asc |
- |
- |
- |
- |
096 [1] 96 💬 |
86 |
Allo-asc-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
87 |
Allogeneic bone marrow derived human mesenchymal stem cells (hmscs) |
- |
- |
- |
- |
096 [1] 96 💬 |
88 |
Allogeneic stem cell therapy |
- |
- |
- |
- |
096 [1] 96 💬 |
89 |
Allogenic eascs 5 milion cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
90 |
Allogenic eascs 5 million cells/ml suspension for injection cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
91 |
Allogenic eascs 5 million cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
92 |
Allogenic eascs 5 million/ml suspension for injection. |
- |
- |
- |
- |
096 [1] 96 💬 |
93 |
Allopurinol |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 [6] 6 , 46, 57, 66, 96, 97 💬 |
94 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 [1] 96 💬 |
95 |
Allopurinol sodium |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 [1] 96 💬 |
96 |
Alofisel |
- |
- |
- |
- |
096 [1] 96 💬 |
97 |
Alx-0600 |
- |
- |
- |
- |
096 [1] 96 💬 |
98 |
Amg 139 |
- |
- |
- |
- |
096 [1] 96 💬 |
99 |
Amg 181 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
100 |
Amg 827 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
101 |
Amg 827 210 mg |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
102 |
Amg 827 350 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
103 |
Amg 827 700 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
104 |
Amgevita |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
105 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
106 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
107 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
108 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
109 |
Amgevita® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
110 |
Aminolevulinic acid |
Aminolevulinic acid |
[2] D02908 D02908, D07567 D07567 💬 |
- |
- |
034 [3] 34, 96, 286 💬 |
111 |
Aminosalicylic acid |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [2] 96, 97 💬 |
112 |
Ammonium chloride |
Ammonium chloride |
[1] D01139 D01139 💬 |
- |
- |
096 [1] 96 💬 |
113 |
Amoxicillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 [7] 6 , 46, 63, 96, 97, 222, 299 💬 |
114 |
An100226 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
115 |
Andecaliximab |
- |
- |
- |
- |
046 [4] 46, 96, 97, 299 💬 |
116 |
Andosan |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
117 |
Anti tnf |
- |
- |
- |
- |
096 [1] 96 💬 |
118 |
Anti tnf alfa. |
- |
- |
- |
- |
096 [1] 96 💬 |
119 |
Anti tnf humanized antibody fab fragment-peg conjugate |
- |
- |
- |
- |
096 [1] 96 💬 |
120 |
Anti tnf therapy including infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
121 |
Anti-cd3 |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
122 |
Anti-cd3 monoclonal antibody |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
123 |
Anti-il-12 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
124 |
Anti-il-23 monoclonal antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
125 |
Anti-il-6 mab |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
126 |
Anti-interferon-gamma monoclonal antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
127 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
128 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
129 |
Anti-interleukin-6 monoclonal antibody |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
130 |
Anti-madcam antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
131 |
Anti-thymocyte globulin (rabbit) |
Rabbit |
- |
- |
- |
060 [4] 60, 65, 96, 285 💬 |
132 |
Anti-tnf |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
133 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
134 |
Anti-tnf drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
135 |
Anti-tnf therapy |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
136 |
Anti-tnf: infliximab (infusion) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
137 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
138 |
Anticorpo monoclonale anti il-23 |
- |
- |
- |
- |
096 [1] 96 💬 |
139 |
Anticorpo monoclonale anti-il-23 |
- |
- |
- |
- |
096 [1] 96 💬 |
140 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
141 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
142 |
Apd334 |
- |
- |
- |
- |
093 [4] 93, 96, 97, 269 💬 |
143 |
Apd371 |
- |
- |
- |
- |
096 [1] 96 💬 |
144 |
Apixaban |
Apixaban |
[1] D03213 D03213 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
096 [3] 96, 97, 222 💬 |
145 |
Apixaban 2.5 milligram |
Apixaban |
[1] D03213 D03213 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
096 [2] 96, 97 💬 |
146 |
Application of adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
147 |
Ar401959 l-arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
096 [2] 96, 97 💬 |
148 |
Arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
046 [9] 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
149 |
As |
- |
- |
- |
- |
046 [6] 46, 53, 96, 97, 215, 271 💬 |
150 |
Asa |
- |
- |
- |
- |
013 [4] 13, 96, 97, 251 💬 |
151 |
Asc |
- |
- |
- |
- |
036 [4] 36, 51, 96, 97 💬 |
152 |
Ascs |
- |
- |
- |
- |
053 [2] 53, 96 💬 |
153 |
Ascs: adipose derived stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
154 |
Ast-120 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
155 |
Atg |
- |
- |
- |
- |
013 [4] 13, 60, 96, 285 💬 |
156 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
157 |
Autologous adipose derived stromal vascular fraction |
- |
- |
- |
- |
096 [1] 96 💬 |
158 |
Autologous cd34-selected peripheral blood stem cells transplant |
- |
- |
- |
- |
096 [1] 96 💬 |
159 |
Autologous mesenchymal stromal cell |
- |
- |
- |
- |
096 [2] 96, 298 💬 |
160 |
Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population |
- |
- |
- |
- |
096 [1] 96 💬 |
161 |
Autologous stem cell transplantation |
- |
- |
- |
- |
056 [2] 56, 96 💬 |
162 |
Aza |
- |
- |
- |
- |
011 [4] 11, 40, 96, 97 💬 |
163 |
Azathioprin |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
164 |
Azathioprin-ratiopharm 25 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
165 |
Azathioprin-ratiopharm 25mg filmtabletten |
- |
- |
- |
- |
096 [1] 96 💬 |
166 |
Azathioprin-ratiopharm 50 mg filmtabletten |
- |
- |
- |
- |
096 [1] 96 💬 |
167 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
168 |
Azathioprine (aza) caps |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
169 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
170 |
Azathioprine - ratiopharm 50 mg |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
171 |
Azathioprine / 6 mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [1] 96 💬 |
172 |
Azathioprine in case of endoscopic recurrence |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
173 |
Azathioprine individualised dose |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
174 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
175 |
Azathioprine or adalimumab and infliximab |
Adalimumab |
[4] D00238 D00238, D02597 D02597, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
176 |
Azathioprine or mesalazine |
Azathioprine |
[3] D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
177 |
Azathioprine or methotrexate |
Azathioprine |
[4] D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [1] 96 💬 |
178 |
Azathioprine weight-based dose |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
179 |
Azathioprine+enteral nutrition |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
180 |
Azatioprina |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [3] 13, 96, 97 💬 |
181 |
Azd9056 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
182 |
Azithromycin |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 [6] 13, 84, 85, 96, 228, 299 💬 |
183 |
Azithromycin + metronidazole |
Azithromycin |
[6] D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 [1] 96 💬 |
184 |
B. theta |
- |
- |
- |
- |
096 [1] 96 💬 |
185 |
Bacteriophage preparation |
- |
- |
- |
- |
096 [1] 96 💬 |
186 |
Bacteriotherapy |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
187 |
Bean |
Bean |
- |
- |
- |
096 [1] 96 💬 |
188 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
189 |
Behavioral: diet counseling |
- |
- |
- |
- |
096 [1] 96 💬 |
190 |
Behavioral: dyadic psychological support (dps) |
- |
- |
- |
- |
096 [1] 96 💬 |
191 |
Behavioral: hypnosis |
- |
- |
- |
- |
096 [1] 96 💬 |
192 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
193 |
Beta carotene |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
096 [1] 96 💬 |
194 |
Beta carotene from dunaliella algae |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
096 [1] 96 💬 |
195 |
Betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [6] 2 , 28, 46, 90, 96, 235 💬 |
196 |
Bezlotoxumab |
Bezlotoxumab |
[1] D10453 D10453 💬 |
- |
- |
096 [2] 96, 97 💬 |
197 |
Bfahf-2 |
- |
- |
- |
- |
096 [1] 96 💬 |
198 |
Bi 655066 |
- |
- |
- |
- |
096 [2] 96, 271 💬 |
199 |
Bi 655066 10 mg/ml |
- |
- |
- |
- |
096 [1] 96 💬 |
200 |
Bi 655066 90 mg/ml |
- |
- |
- |
- |
096 [2] 96, 271 💬 |
201 |
Bi 655130 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
202 |
Bi 695501 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
203 |
Bibr 796 bs, 20 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
204 |
Bibr 796 bs, 5 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
205 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 [2] 96, 97 💬 |
206 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 [2] 96, 97 💬 |
207 |
Biological samplings |
- |
- |
- |
- |
096 [1] 96 💬 |
208 |
Biosimilar |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
209 |
Biosimilar infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
210 |
Bleomycin |
Bleomycin |
[3] D02177 D02177, D03229 D03229, D07535 D07535 💬 |
- |
- |
096 [4] 96, 278, 279, 280 💬 |
211 |
Bli-1300 high dose |
- |
- |
- |
- |
096 [1] 96 💬 |
212 |
Bli-1300 low dose |
- |
- |
- |
- |
096 [1] 96 💬 |
213 |
Blood and stools samples |
- |
- |
- |
- |
096 [1] 96 💬 |
214 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
215 |
Bms-188667 |
- |
- |
- |
- |
046 [8] 46, 49, 53, 65, 96, 97, 222, 271 💬 |
216 |
Bms-936557 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
217 |
Bms-936557 (anti-ip-10 antibody) |
- |
- |
- |
- |
096 [1] 96 💬 |
218 |
Bms-945429 |
Clazakizumab |
[1] D10312 D10312 💬 |
- |
- |
046 [2] 46, 96 💬 |
219 |
Bms-986165 |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
220 |
Bms986165 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
221 |
Bone marrow derived mesenchymal stem cells (mscs) |
- |
- |
- |
- |
096 [1] 96 💬 |
222 |
Boulardii |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
223 |
Brazikumab |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
224 |
Brazikumab high dose |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
225 |
Brazikumab iv infusion |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
226 |
Brazikumab low dose |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
227 |
Brazikumab sc injection |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
228 |
Bt-11 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
229 |
Bt-11 1,000 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
230 |
Bt-11 1000mg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
231 |
Bt-11 500 mg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
232 |
Bt-11 active |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
233 |
Budenofalk |
- |
- |
- |
- |
096 [1] 96 💬 |
234 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 [1] 96 💬 |
235 |
Budenofalk 9mg gastro-resistant granules |
- |
- |
- |
- |
096 [1] 96 💬 |
236 |
Budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
237 |
Budesonide ( zentacort capsules 3mg ) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
238 |
Bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [8] 46, 51, 53, 70, 96, 168, 226, 298 💬 |
239 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
240 |
Bupropion |
Bupropion |
[3] D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 [5] 8 , 18, 21, 96, 171 💬 |
241 |
By demand |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
242 |
C326, il-6 inhibitory avimer protein |
- |
- |
- |
- |
096 [1] 96 💬 |
243 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
244 |
Caffeine 100 mg |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
245 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 [2] 96, 97 💬 |
246 |
Calcitriol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 [8] 37, 46, 49, 66, 96, 158, 235, 326 💬 |
247 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
248 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
249 |
Caltrate pill |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
250 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
251 |
Cannabidiol , synthetic form |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
096 [1] 96 💬 |
252 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
253 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 [5] 2 , 6 , 13, 96, 97 💬 |
254 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
255 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
256 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
257 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
258 |
Cc-5013 |
- |
- |
- |
- |
028 [2] 28, 96 💬 |
259 |
Ccx282-b |
- |
- |
- |
- |
096 [1] 96 💬 |
260 |
Cd |
- |
- |
- |
- |
006 [6] 6 , 46, 51, 96, 97, 265 💬 |
261 |
Cdp6038 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
262 |
Cdp870 |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
263 |
Celebrex |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
264 |
Cellulose |
Microcrystalline cellulose |
[1] D00093 D00093 💬 |
- |
- |
035 [4] 35, 53, 96, 162 💬 |
265 |
Certican |
- |
- |
- |
- |
067 [4] 67, 96, 158, 228 💬 |
266 |
Certolizumab |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
267 |
Certolizumab pegol |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 [6] 37, 46, 96, 97, 226, 271 💬 |
268 |
Certolizumab pegol (cdp870) |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 96 💬 |
269 |
Certolizumab pegol (cdp870, czp) |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
270 |
Certolizumab pegol (czp) |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 271 💬 |
271 |
Certolizumab pegol (rinn) |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
272 |
Certolizumab pegol /cimzia |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
273 |
Certolizumab pegol 400 mg |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
274 |
Chadox2 hav |
- |
- |
- |
- |
096 [1] 96 💬 |
275 |
Chenodeoxycholic acid |
Chenodeoxycholic acid |
[1] D00163 D00163 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
020 [4] 20, 96, 234, 263 💬 |
276 |
Chenodiol |
Chenodeoxycholic acid |
[1] D00163 D00163 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
096 [1] 96 💬 |
277 |
Chenofalk |
- |
- |
- |
- |
096 [1] 96 💬 |
278 |
Chimeric igg1 monoclonal antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
279 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
280 |
Chlorure de sodium |
- |
- |
- |
- |
096 [1] 96 💬 |
281 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
282 |
Cholecalciferol 10,000 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
283 |
Cholecalciferol 400 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
284 |
Cholecalciferol concentrate |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
285 |
Cholecalciferol concentrate (water-dispersible form) |
Cholecalciferol |
[2] D00001 D00001, D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
286 |
Cholestagel |
- |
- |
- |
- |
096 [1] 96 💬 |
287 |
Chondroitin sulfate |
Chondroitin sulfate |
[1] D00080 D00080 💬 |
- |
- |
096 [2] 96, 226 💬 |
288 |
Cimzia |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
289 |
Cimzia 200 mg solution for injection |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
290 |
Ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
002 [5] 2 , 60, 96, 97, 299 💬 |
291 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
096 [2] 96, 299 💬 |
292 |
Clarithromycin |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [8] 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
293 |
Clofarabine |
Clofarabine |
[1] D03546 D03546 💬 |
POLA1 [3] POLA1, POLA2, RRM1 💬 |
DNA replication [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 [9] 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
294 |
Clofazimine |
Clofazimine |
[1] D00278 D00278 💬 |
- |
- |
096 [1] 96 💬 |
295 |
Cnto 1275 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
296 |
Cnto1275 |
- |
- |
- |
- |
046 [6] 46, 49, 84, 93, 96, 97 💬 |
297 |
Cnto1959 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
298 |
Coffee |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
299 |
Colecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [4] 13, 46, 96, 228 💬 |
300 |
Colecalciferol d3 (vigantol oil) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
301 |
Colesevelam |
Colesevelam |
[2] D03582 D03582, D07743 D07743 💬 |
- |
- |
096 [2] 96, 260 💬 |
302 |
Colony-purified bacteroides thetaiotaomicron (b.theta) |
- |
- |
- |
- |
096 [1] 96 💬 |
303 |
Contrast enhanced ultrasound |
- |
- |
- |
- |
096 [1] 96 💬 |
304 |
Cortecosteroid |
- |
- |
- |
- |
096 [1] 96 💬 |
305 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
306 |
Cosmofer |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
307 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
308 |
Cp |
- |
- |
- |
- |
006 [6] 6 , 46, 96, 97, 107, 271 💬 |
309 |
Cp-461 |
- |
- |
- |
- |
096 [1] 96 💬 |
310 |
Cp-690,550 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
311 |
Cp-690,550-10 |
- |
- |
- |
- |
046 [5] 46, 96, 97, 107, 271 💬 |
312 |
Cpsi-2364 |
- |
- |
- |
- |
096 [1] 96 💬 |
313 |
Crohn's disease |
- |
- |
- |
- |
096 [1] 96 💬 |
314 |
Crohns disease exclusion diet + pen |
- |
- |
- |
- |
096 [1] 96 💬 |
315 |
Crown |
- |
- |
- |
- |
096 [1] 96 💬 |
316 |
Ct-p13 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
317 |
Ct-p13 sc (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
318 |
Ctla4ig |
- |
- |
- |
- |
046 [4] 46, 49, 96, 271 💬 |
319 |
Curcuma |
- |
- |
- |
- |
096 [1] 96 💬 |
320 |
Curcuma longa |
Turmeric |
- |
- |
- |
096 [2] 96, 299 💬 |
321 |
Curcuma longa rhizoma |
Turmeric |
- |
- |
- |
096 [1] 96 💬 |
322 |
Curcumin |
Curcumin |
- |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
323 |
Cx401 |
- |
- |
- |
- |
096 [1] 96 💬 |
324 |
Cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
325 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
326 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [4] 13, 60, 96, 256 💬 |
327 |
Cyltezo |
- |
- |
- |
- |
096 [1] 96 💬 |
328 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
329 |
Cytoxan |
- |
- |
- |
- |
060 [2] 60, 96 💬 |
330 |
D-cura |
- |
- |
- |
- |
096 [1] 96 💬 |
331 |
D9421-c |
- |
- |
- |
- |
096 [1] 96 💬 |
332 |
D9421-c capsule 3 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
333 |
D9421-c, 15mg |
- |
- |
- |
- |
096 [1] 96 💬 |
334 |
D9421-c, 9mg |
- |
- |
- |
- |
096 [1] 96 💬 |
335 |
Darvadstrocel |
- |
- |
- |
- |
096 [1] 96 💬 |
336 |
Db adalimumab 40 mg eow |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
337 |
Db adalimumab 40 mg ew |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
338 |
Decortin 20 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
339 |
Decortin 5 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
340 |
Dehydroepiandrosterone |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [5] 49, 53, 83, 96, 113 💬 |
341 |
Dehydroepiandrosterone [dhea] |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
096 [1] 96 💬 |
342 |
Dekristol 20.000 ie |
- |
- |
- |
- |
096 [1] 96 💬 |
343 |
Delayed release 6 mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [1] 96 💬 |
344 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
345 |
Denosumab |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [7] 46, 50, 93, 95, 96, 274, 299 💬 |
346 |
Device: capsule endoscopy |
- |
- |
- |
- |
096 [1] 96 💬 |
347 |
Device: cellulose |
Microcrystalline cellulose |
[1] D00093 D00093 💬 |
- |
- |
096 [1] 96 💬 |
348 |
Device: contrast enhanced ultrasound |
- |
- |
- |
- |
096 [1] 96 💬 |
349 |
Device: endopath from itamar medical - fda approved device. |
- |
- |
- |
- |
096 [1] 96 💬 |
350 |
Device: fluorescence endoscopy and spectroscopy |
- |
- |
- |
- |
096 [1] 96 💬 |
351 |
Device: magnetic resonance enterography (mre) |
- |
- |
- |
- |
096 [1] 96 💬 |
352 |
Device: pma-zeolite |
- |
- |
- |
- |
096 [1] 96 💬 |
353 |
Device: ultrasound elastography |
- |
- |
- |
- |
096 [1] 96 💬 |
354 |
Device: ultrasound imaging |
- |
- |
- |
- |
096 [1] 96 💬 |
355 |
Device: ultrasound vascularity |
- |
- |
- |
- |
096 [1] 96 💬 |
356 |
Dexametasona |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
357 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
358 |
Dexamethasone sodium phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [3] 65, 70, 96 💬 |
359 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
360 |
Dextran |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
002 [5] 2 , 62, 79, 96, 97 💬 |
361 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
362 |
Dextromethorphan 30 mg |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 [2] 96, 97 💬 |
363 |
Dhea |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [3] 49, 86, 96 💬 |
364 |
Diagnostic test: 18f-fdg and 68ga-fapi pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
096 [1] 96 💬 |
365 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
096 [2] 96, 97 💬 |
366 |
Diet 1 |
- |
- |
- |
- |
096 [1] 96 💬 |
367 |
Diet 2 |
- |
- |
- |
- |
096 [1] 96 💬 |
368 |
Dietary therapy |
- |
- |
- |
- |
096 [1] 96 💬 |
369 |
Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon |
Ammonium chloride |
[1] D01139 D01139 💬 |
- |
- |
096 [1] 96 💬 |
370 |
Diflucan |
Fluconazole |
[2] D00322 D00322, D01429 D01429 💬 |
- |
- |
096 [1] 96 💬 |
371 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
372 |
Dlx105 |
- |
- |
- |
- |
096 [1] 96 💬 |
373 |
Doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 [15] 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
374 |
Doxycycline hyclate |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 [3] 23, 96, 227 💬 |
375 |
E-device |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
376 |
E6011 |
- |
- |
- |
- |
046 [3] 46, 93, 96 💬 |
377 |
E6011 10 mg/kg |
- |
- |
- |
- |
096 [1] 96 💬 |
378 |
E6011 15 mg/kg |
- |
- |
- |
- |
096 [1] 96 💬 |
379 |
E6011 2 mg/kg |
- |
- |
- |
- |
096 [1] 96 💬 |
380 |
E6011 5 mg/kg |
- |
- |
- |
- |
096 [1] 96 💬 |
381 |
Early immunosuppressants (azathioprine, methotrexate) |
Azathioprine |
[4] D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [1] 96 💬 |
382 |
Eb8018 |
- |
- |
- |
- |
096 [1] 96 💬 |
383 |
Eb8018 (first-in-class fimh blocker) |
- |
- |
- |
- |
096 [1] 96 💬 |
384 |
Een |
- |
- |
- |
- |
096 [1] 96 💬 |
385 |
Een intervention group |
- |
- |
- |
- |
096 [1] 96 💬 |
386 |
Efalizumab |
Efalizumab |
[1] D03959 D03959 💬 |
ITGAL [1] ITGAL 💬 |
Cell adhesion molecules [12] Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 [8] 11, 13, 37, 46, 53, 61, 95, 96 💬 |
387 |
Egg |
Egg |
- |
- |
- |
096 [2] 96, 310 💬 |
388 |
Egg albumen powder |
Egg |
- |
- |
- |
096 [1] 96 💬 |
389 |
Egg white |
Egg |
- |
- |
- |
096 [1] 96 💬 |
390 |
Egg white protein |
Egg |
- |
- |
- |
096 [1] 96 💬 |
391 |
Eicosapentaenoic acid |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
049 [5] 49, 96, 97, 296, 297 💬 |
392 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
393 |
Emea/h/c/002778 |
- |
- |
- |
- |
096 [1] 96 💬 |
394 |
Endoxan |
- |
- |
- |
- |
013 [7] 13, 28, 43, 44, 85, 96, 222 💬 |
395 |
Endoxan baxter |
- |
- |
- |
- |
013 [3] 13, 43, 96 💬 |
396 |
Entecavir |
Entecavir |
[2] D04008 D04008, D07896 D07896 💬 |
- |
- |
046 [5] 46, 56, 96, 97, 271 💬 |
397 |
Enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
398 |
Enteral nutrition. |
- |
- |
- |
- |
096 [1] 96 💬 |
399 |
Entocort |
- |
- |
- |
- |
096 [1] 96 💬 |
400 |
Entocort cr |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
401 |
Entocort® kapseln |
- |
- |
- |
- |
096 [1] 96 💬 |
402 |
Entyvio |
- |
- |
- |
- |
094 [3] 94, 96, 97 💬 |
403 |
Epanova |
- |
- |
- |
- |
096 [1] 96 💬 |
404 |
Epanova™ (omega-3 free fatty acids) |
Omega-3 fatty acids |
- |
- |
- |
096 [1] 96 💬 |
405 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 [2] 96, 97 💬 |
406 |
Epinephrine |
Epinephrine |
[3] D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [2] 46, 96 💬 |
407 |
Erb-041 |
- |
- |
- |
- |
046 [3] 46, 96, 226 💬 |
408 |
Ergocalciferol |
Ergocalciferol |
[1] D00187 D00187 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [5] 46, 84, 96, 97, 299 💬 |
409 |
Ery-dex |
- |
- |
- |
- |
096 [1] 96 💬 |
410 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
411 |
Eskazole |
Albendazole |
[1] D00134 D00134 💬 |
- |
- |
096 [1] 96 💬 |
412 |
Etiprednol dicloacetate |
Etiprednol dicloacetate |
[1] D04100 D04100 💬 |
- |
- |
096 [1] 96 💬 |
413 |
Etrasimod |
Etrasimod |
[1] D10930 D10930 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [2] 96, 97 💬 |
414 |
Etrasimod l-arginine |
Arginine |
[2] D02982 D02982, D10930 D10930 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [2] 96, 97 💬 |
415 |
Etrolizumab |
Etrolizumab |
[1] D09901 D09901 💬 |
ITGB7 [1] ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [11] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 [2] 96, 97 💬 |
416 |
Eu/1/03/268/002 |
- |
- |
- |
- |
096 [1] 96 💬 |
417 |
Eu/1/99/116/003 |
- |
- |
- |
- |
096 [1] 96 💬 |
418 |
Evaluation of biological predictive factors of clinical response to ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
419 |
Everolimus |
Everolimus |
[1] D02714 D02714 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
034 [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 |
420 |
Exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
421 |
Exclusive enteral nutrition therapy |
- |
- |
- |
- |
096 [1] 96 💬 |
422 |
Expanded allogenic adipose-derived adult stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
423 |
Expanded autologous adipose-derived adult stem cells (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
424 |
Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
425 |
Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
426 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue |
- |
- |
- |
- |
096 [1] 96 💬 |
427 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs |
- |
- |
- |
- |
096 [1] 96 💬 |
428 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
429 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
430 |
Fe 999301 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
431 |
Fecal microbial transplant |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
432 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
433 |
Fecal microbiota |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
434 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
435 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
436 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 [5] 2 , 66, 94, 96, 97 💬 |
437 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
438 |
Ferric carboxy maltose |
Maltose |
[1] D00044 D00044 💬 |
- |
- |
096 [1] 96 💬 |
439 |
Ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [4] 86, 96, 97, 299 💬 |
440 |
Ferric maltol |
Ferric maltol |
[1] D10833 D10833 💬 |
- |
- |
096 [1] 96 💬 |
441 |
Ferrous sulphate |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
442 |
Ffp104 |
- |
- |
- |
- |
093 [2] 93, 96 💬 |
443 |
Filgotinib |
Filgotinib |
[1] D10871 D10871 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [6] 46, 53, 96, 97, 222, 271 💬 |
444 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
445 |
Fish oil |
Fish oil |
- |
- |
- |
013 [7] 13, 46, 49, 66, 96, 260, 299 💬 |
446 |
Fitc-adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
447 |
Flagyl |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
448 |
Flixabi |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
449 |
Fluconazole |
Fluconazole |
[2] D00322 D00322, D01429 D01429 💬 |
- |
- |
096 [2] 96, 225 💬 |
450 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
451 |
Fludarabine phosphate |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 [11] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
452 |
Fmt |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
453 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 [4] 13, 46, 49, 96 💬 |
454 |
Fos |
- |
- |
- |
- |
066 [2] 66, 96 💬 |
455 |
Fosfato sodico de dexametasona |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
456 |
Fosfomycin |
Fosfomycin |
[4] D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 [2] 96, 97 💬 |
457 |
Fully humanised, recombinant monoclonal antibody (igg1) |
- |
- |
- |
- |
096 [1] 96 💬 |
458 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
459 |
G321605 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
460 |
Ged-0301 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
461 |
Genetic: genetic analysis |
- |
- |
- |
- |
096 [1] 96 💬 |
462 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
463 |
Glatiramer |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [4] 2 , 13, 96, 156 💬 |
464 |
Glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [3] 13, 96, 156 💬 |
465 |
Glpg0634 |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
466 |
Glpg1205 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
467 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
468 |
Glutamine |
L-Glutamine |
[1] D00015 D00015 💬 |
- |
- |
087 [7] 87, 89, 96, 97, 113, 245, 299 💬 |
469 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
470 |
Golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [6] 46, 56, 84, 96, 97, 271 💬 |
471 |
Green tea |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
006 [5] 6 , 17, 28, 46, 96 💬 |
472 |
Group 2 ustekinumab 130 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
473 |
Group 3: ustekinumab approximately 6 mg/kg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
474 |
Growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [12] 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
475 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 [4] 46, 96, 97, 299 💬 |
476 |
Gs-6034 |
- |
- |
- |
- |
046 [4] 46, 53, 96, 97 💬 |
477 |
Gsk1070806 |
- |
- |
- |
- |
056 [2] 56, 96 💬 |
478 |
Gsk1605786 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
479 |
Gsk1605786 500 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
480 |
Gsk1605786 capsule |
- |
- |
- |
- |
096 [1] 96 💬 |
481 |
Gsk1605786 chemocentryx: formulation a |
- |
- |
- |
- |
096 [1] 96 💬 |
482 |
Gsk1605786 gsk direct-fill: formulation c |
- |
- |
- |
- |
096 [1] 96 💬 |
483 |
Gsk1605786 gsk modified-process: formulation d |
- |
- |
- |
- |
096 [1] 96 💬 |
484 |
Gsk1605786 gsk tablet: formulation e |
- |
- |
- |
- |
096 [1] 96 💬 |
485 |
Gsk1605786 gsk: formulation b |
- |
- |
- |
- |
096 [1] 96 💬 |
486 |
Gsk1605786a |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
487 |
Gsk2330811 |
- |
- |
- |
- |
051 [2] 51, 96 💬 |
488 |
Guselkumab |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [4] 37, 41, 96, 97 💬 |
489 |
Guselkumab dose 1 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
490 |
Guselkumab dose 2 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
491 |
Guselkumab dose 3 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
492 |
Guselkumab dose 4 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
493 |
Guselkumab dose 5 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
494 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
495 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
496 |
Herpes zoster vaccine |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
497 |
Hextend |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
498 |
High dose tso |
- |
- |
- |
- |
096 [1] 96 💬 |
499 |
High oligosaccharide group |
- |
- |
- |
- |
096 [1] 96 💬 |
500 |
High-dose cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
096 [1] 96 💬 |
501 |
Hmpl-004 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
502 |
Hmpl004-6599 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
503 |
Hulio |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
504 |
Hum291 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
505 |
Human albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
002 [2] 2 , 96 💬 |
506 |
Human albumin as macroaggregates |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
096 [1] 96 💬 |
507 |
Human anti-il-12 antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
508 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
509 |
Human insulin |
Insulin human |
[2] D00085 D00085, D03230 D03230 💬 |
INSR [1] INSR 💬 |
AMPK signaling pathway [22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway |
096 [2] 96, 156 💬 |
510 |
Human monoclonal antibody (cnto 1275) to interleukin 12p-40 |
- |
- |
- |
- |
096 [1] 96 💬 |
511 |
Human placenta-derived cells pda001 intravenous infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
512 |
Human plasma for fractionation |
- |
- |
- |
- |
096 [1] 96 💬 |
513 |
Humira |
- |
- |
- |
- |
046 [7] 46, 84, 96, 97, 160, 269, 271 💬 |
514 |
Humira (adalimumab original) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
515 |
Humira (adalimumab) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 96 💬 |
516 |
Humira 20 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
517 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 [1] 96 💬 |
518 |
Humira 40 mg solución inyectable en jeringa precargada |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
519 |
Humira 40 mg solution for injection in pre-filled pen |
- |
- |
- |
- |
096 [1] 96 💬 |
520 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
521 |
Humira 40 mg/0.8 ml solution for injection |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
522 |
Humira 40mg solution for injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
523 |
Humira 40mg/0.4ml pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
524 |
Humira 40mg/0.8ml solution for injection for paediatric use |
- |
- |
- |
- |
096 [1] 96 💬 |
525 |
Humira pre-filled pen |
- |
- |
- |
- |
096 [1] 96 💬 |
526 |
Humira ® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
527 |
Humira*sc 2sir+f 40mg 0,8ml+2t |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
528 |
Humira® |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
529 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 [4] 46, 96, 97, 284 💬 |
530 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
531 |
Hydroxychloroquine sulphate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
096 [1] 96 💬 |
532 |
Igg2 antibodies |
- |
- |
- |
- |
096 [1] 96 💬 |
533 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 [6] 2 , 46, 49, 53, 56, 96 💬 |
534 |
Im90838 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
535 |
Immune ablation and hematopoietic stem cell support |
- |
- |
- |
- |
096 [1] 96 💬 |
536 |
Immunonutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
537 |
Immunosuppressor/tnfalpha |
- |
- |
- |
- |
096 [1] 96 💬 |
538 |
Imp will be labeled as ''pf-04236921 106mg/vial, clonal sc lyophilized form''. |
- |
- |
- |
- |
096 [1] 96 💬 |
539 |
Imp will be labeled as pf-04236921 106mg/vial, clonal sc lyophilized form |
- |
- |
- |
- |
096 [1] 96 💬 |
540 |
Impact |
- |
- |
- |
- |
006 [8] 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
541 |
Imraldi |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
542 |
Imu-838 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
543 |
Imuran |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
544 |
Imurel |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
545 |
Imurel 25 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
546 |
Increlex |
- |
- |
- |
- |
065 [4] 65, 78, 96, 299 💬 |
547 |
Increlex 10mg/ml solution for injection |
- |
- |
- |
- |
096 [1] 96 💬 |
548 |
Indocyanine green |
Indocyanine green |
[1] D01342 D01342 💬 |
- |
- |
046 [7] 46, 51, 96, 235, 278, 291, 296 💬 |
549 |
Inflectra |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
550 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
551 |
Infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 [24] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
552 |
Infliximab (ifx alone) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
553 |
Infliximab (remicade) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 271 💬 |
554 |
Infliximab (remicade): 100 mg of lyophilized infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
555 |
Infliximab 10 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
556 |
Infliximab 20 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
557 |
Infliximab 5 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
558 |
Infliximab 5 mg/kg body weight infused over 2 hours |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
559 |
Infliximab 5 mg/kg every 6 weeks |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
560 |
Infliximab 7 mg/kg every 8 weeks |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
561 |
Infliximab [infliximab biosimilar 3] |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 [4] 37, 46, 96, 97 💬 |
562 |
Infliximab and adalimumab |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
563 |
Infliximab and azathioprine combination at week 0 |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
564 |
Infliximab and azathioprine combination at week 14 |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
565 |
Infliximab infusion |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
566 |
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab |
Adalimumab |
[5] D02597 D02597, D02598 D02598, D04358 D04358, D08083 D08083, D09214 D09214 💬 |
IL12A [6] IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
567 |
Infliximab with azathioprine (iifx + aza) |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
568 |
Infliximab+azathioprine |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
569 |
Infliximab, adalimumab, certolizumab pegol |
Adalimumab |
[3] D02597 D02597, D02598 D02598, D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
570 |
Infliximab, azathioprine |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
571 |
Infliximab-biosimilar |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
572 |
Infliximab-innovator |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
573 |
Injection of iron |
- |
- |
- |
- |
096 [1] 96 💬 |
574 |
Innovator infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
575 |
Inositol |
Inositol |
[1] D08079 D08079 💬 |
- |
- |
096 [2] 96, 97 💬 |
576 |
Interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 [5] 25, 26, 28, 56, 96 💬 |
577 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 [5] 13, 20, 26, 96, 97 💬 |
578 |
Interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [4] 13, 26, 96, 97 💬 |
579 |
Interleukin 2 |
- |
- |
- |
- |
046 [9] 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
580 |
Interleukin-11 |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
096 [2] 96, 288 💬 |
581 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 [8] 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
582 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 [2] 96, 97 💬 |
583 |
Intralipid |
- |
- |
- |
- |
096 [1] 96 💬 |
584 |
Intralipid 10% |
- |
- |
- |
- |
096 [1] 96 💬 |
585 |
Intralipid 20% |
- |
- |
- |
- |
096 [1] 96 💬 |
586 |
Inulin |
Inulin |
[1] D00171 D00171 💬 |
- |
- |
096 [2] 96, 299 💬 |
587 |
Invita d3 |
- |
- |
- |
- |
096 [1] 96 💬 |
588 |
Iron |
Iron |
- |
- |
- |
018 [5] 18, 96, 97, 254, 284 💬 |
589 |
Iron sucrose |
Iron |
[2] D00025 D00025, D04616 D04616 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
590 |
Iron sulphate |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
591 |
Iron sulphate 200mg coated tablets |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
592 |
Iron supplement 300-600 mg/day |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
593 |
Iron(iii)- hydroxide dextran complex |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
096 [2] 96, 97 💬 |
594 |
Itf 2357 |
- |
- |
- |
- |
096 [1] 96 💬 |
595 |
Itf2357 |
- |
- |
- |
- |
096 [4] 96, 107, 113, 267 💬 |
596 |
J695 |
- |
- |
- |
- |
096 [1] 96 💬 |
597 |
J695, bsf 415977 (formerly lu415977), way-165772, a-796874.0 |
- |
- |
- |
- |
096 [1] 96 💬 |
598 |
Jnj-40346527 |
JNJ-40346527 |
- |
- |
- |
046 [2] 46, 96 💬 |
599 |
Jnj-40346527-aac |
JNJ-40346527 |
- |
- |
- |
096 [1] 96 💬 |
600 |
Jnj-64304500 |
- |
- |
- |
- |
096 [1] 96 💬 |
601 |
Jnj-64304500-aaa |
- |
- |
- |
- |
096 [1] 96 💬 |
602 |
Jnj-67864238 |
- |
- |
- |
- |
096 [1] 96 💬 |
603 |
Kanamycin |
Kanamycin |
[3] D00866 D00866, D03262 D03262, D07497 D07497 💬 |
- |
- |
096 [2] 96, 291 💬 |
604 |
Kenacort |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
605 |
Kremezin |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
606 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
096 [2] 96, 97 💬 |
607 |
L 44 |
- |
- |
- |
- |
096 [1] 96 💬 |
608 |
L-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [6] 13, 96, 97, 265, 298, 316 💬 |
609 |
L01ba |
- |
- |
- |
- |
096 [1] 96 💬 |
610 |
Lactated ringers |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
611 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
612 |
Lactulose |
Lactulose |
[1] D00352 D00352 💬 |
- |
- |
096 [2] 96, 291 💬 |
613 |
Lactulose/rhamnose solution |
Lactulose |
[1] D00352 D00352 💬 |
- |
- |
096 [1] 96 💬 |
614 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
615 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 [4] 8 , 13, 49, 96 💬 |
616 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 [2] 8 , 96 💬 |
617 |
Laquinimod cápsulas 0.5 mg |
Laquinimod |
- |
- |
- |
096 [1] 96 💬 |
618 |
Ldp-02 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
619 |
Leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [10] 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
620 |
Lipitor |
- |
- |
- |
- |
051 [3] 51, 96, 299 💬 |
621 |
Liposomal bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [3] 51, 70, 96 💬 |
622 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
623 |
Low dose naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
624 |
Low dose tso |
- |
- |
- |
- |
096 [1] 96 💬 |
625 |
Low-dose il-2 administration |
Human interleukin-2 |
- |
- |
- |
096 [1] 96 💬 |
626 |
Lumbar puncture |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
627 |
Lumentin 44 |
- |
- |
- |
- |
096 [1] 96 💬 |
628 |
Ly3074828 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
629 |
Lymphocyte immune globulin |
- |
- |
- |
- |
096 [1] 96 💬 |
630 |
Maltodextrin |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
006 [4] 6 , 13, 96, 97 💬 |
631 |
Maltose |
Maltose |
[1] D00044 D00044 💬 |
- |
- |
096 [2] 96, 97 💬 |
632 |
Mango |
Mango |
- |
- |
- |
096 [2] 96, 97 💬 |
633 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 [2] 96, 97 💬 |
634 |
Mannitol |
Mannitol |
[1] D00062 D00062 💬 |
- |
- |
006 [4] 6 , 60, 96, 299 💬 |
635 |
Mare´s milk |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
636 |
Masitinib |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
637 |
Masitinib mesylate |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
638 |
Mb-102 |
- |
- |
- |
- |
096 [1] 96 💬 |
639 |
Mdgn-002 |
- |
- |
- |
- |
096 [1] 96 💬 |
640 |
Mdx-1100 |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
641 |
Mecasermin |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 [5] 78, 96, 168, 265, 299 💬 |
642 |
Mecasermin [rdna origin] 10mg/ml solution |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
096 [1] 96 💬 |
643 |
Medi2070 |
- |
- |
- |
- |
096 [1] 96 💬 |
644 |
Medium chain triglycerides |
- |
- |
- |
- |
096 [1] 96 💬 |
645 |
Medium dose tso |
- |
- |
- |
- |
096 [1] 96 💬 |
646 |
Melphalan |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
011 [15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
647 |
Mensa |
- |
- |
- |
- |
096 [1] 96 💬 |
648 |
Mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [3] 96, 97, 164 💬 |
649 |
Mesalamine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [3] 96, 97, 164 💬 |
650 |
Mesalamine, 5-aminosalicylic acid |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
651 |
Mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
046 [3] 46, 96, 97 💬 |
652 |
Mesalazine (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
653 |
Mesalazine ec 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
654 |
Mesalazine sustained-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
655 |
Mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
656 |
Mesalazine, tripterygium glycosides |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
657 |
Mesenchymal cell and fibroblast injection |
- |
- |
- |
- |
096 [1] 96 💬 |
658 |
Mesenchymal cell transplantation |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
659 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 [11] 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
660 |
Mesenchymal stem cells (msc) |
- |
- |
- |
- |
096 [1] 96 💬 |
661 |
Mesenchymal stem cells (mscs) |
- |
- |
- |
- |
013 [3] 13, 36, 96 💬 |
662 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 [9] 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
663 |
Mesenchymal stromal cells (msc) for infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 [1] 96 💬 |
664 |
Mesna |
- |
- |
- |
- |
011 [11] 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
665 |
Methacholine |
Methacholine |
- |
- |
- |
096 [1] 96 💬 |
666 |
Methotrexat |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 [4] 13, 46, 50, 96 💬 |
667 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
668 |
Methotrexate disodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [3] 46, 96, 97 💬 |
669 |
Methotrexate injection |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [2] 96, 97 💬 |
670 |
Methoxsalen |
Methoxsalen |
[1] D00139 D00139 💬 |
- |
- |
036 [3] 36, 46, 96 💬 |
671 |
Methoxsalen +ecp |
Methoxsalen |
[1] D00139 D00139 💬 |
- |
- |
096 [1] 96 💬 |
672 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
673 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
674 |
Methylprednisolone or budesonide |
Budesonide |
[7] D00246 D00246, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
675 |
Metoject |
- |
- |
- |
- |
041 [4] 41, 46, 96, 97 💬 |
676 |
Metotrexat |
- |
- |
- |
- |
050 [2] 50, 96 💬 |
677 |
Metronidazol |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [2] 46, 96 💬 |
678 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
679 |
Microbiota |
- |
- |
- |
- |
096 [1] 96 💬 |
680 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
681 |
Midazolam 2 mg |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 [2] 96, 97 💬 |
682 |
Midazolam 3 mg |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 [1] 96 💬 |
683 |
Mirikizumab |
Mirikizumab |
[1] D11123 D11123 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [3] 37, 96, 97 💬 |
684 |
Mln0002 |
- |
- |
- |
- |
094 [3] 94, 96, 97 💬 |
685 |
Mln0002 (vedolizumab) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
686 |
Mln0002 sc |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
687 |
Mln002 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
688 |
Mobilization of stem cells to prepare for leukapheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
689 |
Moderate oligosaccharide group |
- |
- |
- |
- |
096 [1] 96 💬 |
690 |
Modulen |
- |
- |
- |
- |
096 [1] 96 💬 |
691 |
Modulen ibd |
- |
- |
- |
- |
096 [1] 96 💬 |
692 |
Modulen ibd (r) (specific enteral nutrition) |
- |
- |
- |
- |
096 [1] 96 💬 |
693 |
Mongersen |
Mongersen |
[1] D10956 D10956 💬 |
SMAD7 [1] SMAD7 💬 |
Hippo signaling pathway [2] Hippo signaling pathway, TGF-beta signaling pathway |
096 [2] 96, 97 💬 |
694 |
Monoclonal antibodies |
- |
- |
- |
- |
096 [1] 96 💬 |
695 |
Monoclonal antibody anti-igg1 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
696 |
Monoclonal antibody ca2 |
- |
- |
- |
- |
096 [1] 96 💬 |
697 |
Mosapride |
Mosapride |
[1] D08236 D08236 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
096 [1] 96 💬 |
698 |
Movprep |
- |
- |
- |
- |
096 [1] 96 💬 |
699 |
Msc |
- |
- |
- |
- |
006 [6] 6 , 51, 60, 96, 97, 271 💬 |
700 |
Msc injection 01 |
- |
- |
- |
- |
096 [1] 96 💬 |
701 |
Msc injection 02 |
- |
- |
- |
- |
096 [1] 96 💬 |
702 |
Msc treatment 01 |
- |
- |
- |
- |
096 [1] 96 💬 |
703 |
Msc treatment 02 |
- |
- |
- |
- |
096 [1] 96 💬 |
704 |
Msc-afp |
- |
- |
- |
- |
096 [1] 96 💬 |
705 |
Mt-1303 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
706 |
Mtx |
- |
- |
- |
- |
035 [12] 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
707 |
Mva |
- |
- |
- |
- |
096 [1] 96 💬 |
708 |
Mva hav |
- |
- |
- |
- |
096 [1] 96 💬 |
709 |
Mycodigest supplement |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
710 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
711 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
712 |
Mycophenolic acid |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 [8] 11, 43, 49, 51, 60, 66, 96, 222 💬 |
713 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium |
- |
- |
- |
- |
096 [1] 96 💬 |
714 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium |
- |
- |
- |
- |
096 [1] 96 💬 |
715 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
716 |
Naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [12] 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
717 |
Naltrexone hydrochloride |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
010 [8] 10, 40, 41, 42, 43, 44, 45, 96 💬 |
718 |
Naltrexone-hcl |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
719 |
Nap |
- |
- |
- |
- |
096 [2] 96, 240 💬 |
720 |
Natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [4] 13, 15, 46, 96 💬 |
721 |
Neomycin |
Neomycin |
[1] D08260 D08260 💬 |
- |
- |
096 [3] 96, 97, 296 💬 |
722 |
Nessuno |
- |
- |
- |
- |
096 [1] 96 💬 |
723 |
Ni-0401 (anti-cd3 mab) |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [1] 96 💬 |
724 |
Nitazoxanide |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
096 [2] 96, 97 💬 |
725 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
726 |
Nnc 0142-0000-0002 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
727 |
Nnc0114-0006 |
- |
- |
- |
- |
046 [3] 46, 49, 96 💬 |
728 |
Nnc0142-0000-0002 |
- |
- |
- |
- |
096 [1] 96 💬 |
729 |
Nnc142-0002 |
- |
- |
- |
- |
096 [1] 96 💬 |
730 |
None |
- |
- |
- |
- |
046 [14] 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
731 |
None at this time |
- |
- |
- |
- |
096 [2] 96, 140 💬 |
732 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
733 |
Normix |
- |
- |
- |
- |
096 [1] 96 💬 |
734 |
Normix*ad 12cpr riv 200mg |
- |
- |
- |
- |
096 [1] 96 💬 |
735 |
Nsp001 |
- |
- |
- |
- |
096 [1] 96 💬 |
736 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
737 |
Nutraceutical combination |
- |
- |
- |
- |
096 [1] 96 💬 |
738 |
Nutrition treat |
- |
- |
- |
- |
096 [1] 96 💬 |
739 |
Nutritional dietary intervention |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
740 |
Nutropinaq 10mg/2ml solution for injection |
- |
- |
- |
- |
096 [1] 96 💬 |
741 |
Nutropinaq® |
- |
- |
- |
- |
096 [1] 96 💬 |
742 |
Ol adalimumab 40 mg |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
743 |
Oligofructose enriched inulin |
Inulin |
[1] D00171 D00171 💬 |
- |
- |
096 [1] 96 💬 |
744 |
Olokizumab |
Olokizumab |
- |
- |
- |
046 [2] 46, 96 💬 |
745 |
Olokizumab (okz) |
Olokizumab |
- |
- |
- |
096 [1] 96 💬 |
746 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 [7] 13, 46, 49, 66, 79, 96, 299 💬 |
747 |
Omegaven |
- |
- |
- |
- |
096 [1] 96 💬 |
748 |
Omegaven 10% |
- |
- |
- |
- |
096 [1] 96 💬 |
749 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
750 |
Omeprazole 20 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [2] 96, 97 💬 |
751 |
Omeprazole 40 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
752 |
Only 1 arm: treatment with msc-afp |
- |
- |
- |
- |
096 [1] 96 💬 |
753 |
Ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
754 |
Opc-6535 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
755 |
Opc-6535(tetomilast) |
Tetomilast |
- |
- |
- |
096 [2] 96, 97 💬 |
756 |
Ops-2071 |
- |
- |
- |
- |
096 [1] 96 💬 |
757 |
Ops-2071 150 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
758 |
Ops-2071 300 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
759 |
Ops-2071 600 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
760 |
Optison |
- |
- |
- |
- |
096 [1] 96 💬 |
761 |
Orencia |
- |
- |
- |
- |
044 [13] 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
762 |
Originator (legacy) drug |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
763 |
Other biologic therapies |
- |
- |
- |
- |
096 [1] 96 💬 |
764 |
Other biological agent |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
765 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
766 |
Other: 5-asa withdrawal |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
767 |
Other: acute response to high-impact exercise |
- |
- |
- |
- |
096 [1] 96 💬 |
768 |
Other: blood test |
- |
- |
- |
- |
096 [1] 96 💬 |
769 |
Other: cd lfd |
- |
- |
- |
- |
096 [1] 96 💬 |
770 |
Other: cd-treat diet |
- |
- |
- |
- |
096 [1] 96 💬 |
771 |
Other: coffee |
- |
- |
- |
- |
096 [1] 96 💬 |
772 |
Other: control diet |
- |
- |
- |
- |
096 [1] 96 💬 |
773 |
Other: crohn's disease treatment-with-eating diet (cd-treat diet) |
- |
- |
- |
- |
096 [1] 96 💬 |
774 |
Other: crohns disease exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
775 |
Other: diet-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
776 |
Other: enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
777 |
Other: exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
778 |
Other: exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
779 |
Other: exclusive enteral nutrition (een) |
- |
- |
- |
- |
096 [1] 96 💬 |
780 |
Other: fractional exhaled no (feno) |
- |
- |
- |
- |
096 [1] 96 💬 |
781 |
Other: green tea (camellia sinensis) |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
096 [1] 96 💬 |
782 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 [1] 96 💬 |
783 |
Other: high performance liquid chromatography |
- |
- |
- |
- |
096 [1] 96 💬 |
784 |
Other: high-impact exercise intervention |
- |
- |
- |
- |
096 [1] 96 💬 |
785 |
Other: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
096 [1] 96 💬 |
786 |
Other: infliximab (ifx) infusion |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
787 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
788 |
Other: iv saline infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
789 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
790 |
Other: lengthening adalimumab dosing interval |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
791 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
792 |
Other: low n-6 pufa diet |
- |
- |
- |
- |
096 [1] 96 💬 |
793 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
794 |
Other: methacholine challenge test |
Methacholine |
- |
- |
- |
096 [1] 96 💬 |
795 |
Other: normal diet |
- |
- |
- |
- |
096 [1] 96 💬 |
796 |
Other: ns |
- |
- |
- |
- |
096 [1] 96 💬 |
797 |
Other: other biologic agents |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
798 |
Other: pcdai |
- |
- |
- |
- |
096 [1] 96 💬 |
799 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
800 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
801 |
Other: standard nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
802 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
803 |
Other: stem cell transplant |
- |
- |
- |
- |
096 [1] 96 💬 |
804 |
Other: surgery |
- |
- |
- |
- |
074 [2] 74, 96 💬 |
805 |
Other: threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
096 [2] 96, 97 💬 |
806 |
Other: triangular test |
- |
- |
- |
- |
096 [1] 96 💬 |
807 |
Other: uc-mscs by peripheral intravenous infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 [1] 96 💬 |
808 |
Ova-treg |
- |
- |
- |
- |
096 [1] 96 💬 |
809 |
Ovasave |
- |
- |
- |
- |
096 [1] 96 💬 |
810 |
Oxadrop |
- |
- |
- |
- |
096 [1] 96 💬 |
811 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
812 |
Ozanimod |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
813 |
Ozanimod hydrochloride |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
814 |
P28gst |
- |
- |
- |
- |
096 [1] 96 💬 |
815 |
Pda001 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
816 |
Pectin |
Pectin |
[1] D02316 D02316 💬 |
- |
- |
096 [1] 96 💬 |
817 |
Peg |
- |
- |
- |
- |
006 [9] 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
818 |
Pegylated interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
096 [1] 96 💬 |
819 |
Pending |
- |
- |
- |
- |
013 [6] 13, 19, 96, 97, 113, 302 💬 |
820 |
Pentasa |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
821 |
Pentasa sachet |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
822 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
823 |
Pentasa sachet 1 g prolonged release granules |
- |
- |
- |
- |
096 [1] 96 💬 |
824 |
Pentoxifylline |
Pentoxifylline |
[1] D00501 D00501 💬 |
- |
- |
026 [10] 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
825 |
Peptidic+probiotic |
- |
- |
- |
- |
096 [1] 96 💬 |
826 |
Peripheral blood stem cell infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
827 |
Pf 06687234 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
828 |
Pf-00547659 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
829 |
Pf-00547659 sc injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
830 |
Pf-04236921 |
- |
- |
- |
- |
049 [2] 49, 96 💬 |
831 |
Pf-04236921 sc injection |
- |
- |
- |
- |
096 [1] 96 💬 |
832 |
Pf-06651600 |
PF-06651600 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
833 |
Pf-06651600 50 mg |
PF-06651600 |
- |
- |
- |
096 [2] 96, 97 💬 |
834 |
Pf-06651600-15 |
PF-06651600 |
- |
- |
- |
096 [2] 96, 97 💬 |
835 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
836 |
Pf-06700841 25 mg |
PF-06700841 |
- |
- |
- |
096 [2] 96, 97 💬 |
837 |
Pf-06700841 5 mg |
PF-06700841 |
- |
- |
- |
096 [2] 96, 97 💬 |
838 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
839 |
Pharmacokinetics of certolizumab pegol |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 96 💬 |
840 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
841 |
Phylloquinone |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
096 [1] 96 💬 |
842 |
Phylloquinone (vitamin k1) |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
096 [1] 96 💬 |
843 |
Physician standard-of-care |
- |
- |
- |
- |
096 [1] 96 💬 |
844 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
845 |
Pioglitazone 15 mg |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
096 [1] 96 💬 |
846 |
Pl 17901/0122 |
- |
- |
- |
- |
096 [1] 96 💬 |
847 |
Pl 20532/0012 |
- |
- |
- |
- |
096 [1] 96 💬 |
848 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
849 |
Plantain nsp |
- |
- |
- |
- |
096 [1] 96 💬 |
850 |
Plaquenil |
- |
- |
- |
- |
046 [4] 46, 49, 53, 96 💬 |
851 |
Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti) |
- |
- |
- |
- |
096 [1] 96 💬 |
852 |
Pnemovax |
- |
- |
- |
- |
096 [1] 96 💬 |
853 |
Pneumovax |
- |
- |
- |
- |
046 [3] 46, 49, 96 💬 |
854 |
Polaprezinc |
Polaprezinc |
[1] D01611 D01611 💬 |
- |
- |
096 [2] 96, 97 💬 |
855 |
Polyethylene glycol |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
096 [5] 96, 97, 235, 276, 299 💬 |
856 |
Polyethylene glycol 3350 |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
096 [2] 96, 299 💬 |
857 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
858 |
Postoperative 3-month exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
859 |
Pravastatin |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
860 |
Prebiotics |
- |
- |
- |
- |
096 [1] 96 💬 |
861 |
Prednisolon |
- |
- |
- |
- |
046 [6] 46, 50, 51, 66, 96, 97 💬 |
862 |
Prednisolon jenapharm |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
863 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
864 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
865 |
Preparative regimen 4-6 weeks after leukapheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
866 |
Prevenar 13 |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
867 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
868 |
Previously referred to as medi2070 and amg 139, agn-151-598 |
- |
- |
- |
- |
096 [1] 96 💬 |
869 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
870 |
Probiotic - vsl#3 |
- |
- |
- |
- |
096 [1] 96 💬 |
871 |
Probiotic mixture |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
872 |
Probiotics |
- |
- |
- |
- |
094 [4] 94, 96, 97, 291 💬 |
873 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 [6] 60, 65, 96, 164, 284, 285 💬 |
874 |
Procedure: apheresis catheter placement |
- |
- |
- |
- |
096 [1] 96 💬 |
875 |
Procedure: autologous stem cell transplant |
- |
- |
- |
- |
028 [2] 28, 96 💬 |
876 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
877 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
878 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
879 |
Procedure: blue light photopheresis |
- |
- |
- |
- |
096 [1] 96 💬 |
880 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
881 |
Procedure: computed tomography |
- |
- |
- |
- |
034 [5] 34, 40, 46, 49, 96 💬 |
882 |
Procedure: continuous mononuclear cell collection (cmnc) |
- |
- |
- |
- |
096 [1] 96 💬 |
883 |
Procedure: dexa scan |
- |
- |
- |
- |
019 [3] 19, 46, 96 💬 |
884 |
Procedure: endoscopic balloon dilatation |
- |
- |
- |
- |
096 [1] 96 💬 |
885 |
Procedure: eua with seton placement if necessary |
- |
- |
- |
- |
096 [1] 96 💬 |
886 |
Procedure: eus |
- |
- |
- |
- |
096 [1] 96 💬 |
887 |
Procedure: extracorporeal photopheresis |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
888 |
Procedure: fmt |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
889 |
Procedure: ileocecal resection |
- |
- |
- |
- |
096 [1] 96 💬 |
890 |
Procedure: ileocolonoscopy |
- |
- |
- |
- |
096 [1] 96 💬 |
891 |
Procedure: instillation of fibrin glue |
- |
- |
- |
- |
096 [1] 96 💬 |
892 |
Procedure: intestinal surgery for crohn's disease |
- |
- |
- |
- |
096 [1] 96 💬 |
893 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 [5] 49, 51, 96, 284, 285 💬 |
894 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 [5] 6 , 13, 19, 96, 97 💬 |
895 |
Procedure: measurement of serum infliximab and anti-infliximab antibodies |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
896 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 [4] 40, 46, 49, 96 💬 |
897 |
Procedure: routine drainage surgery |
- |
- |
- |
- |
096 [1] 96 💬 |
898 |
Procedure: small bowel follow trough |
- |
- |
- |
- |
096 [1] 96 💬 |
899 |
Procedure: transfusion |
- |
- |
- |
- |
096 [1] 96 💬 |
900 |
Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
901 |
Procedure: whole body protein turnover |
- |
- |
- |
- |
019 [4] 19, 46, 96, 299 💬 |
902 |
Procedure: wmt |
- |
- |
- |
- |
096 [1] 96 💬 |
903 |
Prochymal (remestemcel-l) |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
904 |
Prochymal adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
905 |
Prochymal™ adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [1] 96 💬 |
906 |
Promethazine |
Promethazine |
[4] D00480 D00480, D00494 D00494, D01242 D01242, D03290 D03290 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
907 |
Prucalopride |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 [3] 13, 51, 96 💬 |
908 |
Prv-6527 |
- |
- |
- |
- |
096 [1] 96 💬 |
909 |
Prv-6527 (jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 [1] 96 💬 |
910 |
Prv-6527(jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 [1] 96 💬 |
911 |
Ptg-200 |
- |
- |
- |
- |
096 [1] 96 💬 |
912 |
Puri-nethol |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
913 |
Puri-nethol 50 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
914 |
Purinethol |
- |
- |
- |
- |
096 [1] 96 💬 |
915 |
Qax567 |
- |
- |
- |
- |
096 [1] 96 💬 |
916 |
Qax576 |
- |
- |
- |
- |
051 [4] 51, 85, 96, 98 💬 |
917 |
Qbeco |
- |
- |
- |
- |
096 [1] 96 💬 |
918 |
Qbeco-ssi |
- |
- |
- |
- |
096 [1] 96 💬 |
919 |
Rabbit |
Rabbit |
- |
- |
- |
011 [8] 11, 13, 49, 51, 60, 65, 96, 285 💬 |
920 |
Rabbit anti-human thymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
921 |
Rabbit antithymocyte globulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
049 [3] 49, 60, 96 💬 |
922 |
Racol |
- |
- |
- |
- |
006 [3] 6 , 96, 291 💬 |
923 |
Rad001 |
- |
- |
- |
- |
034 [6] 34, 67, 89, 96, 158, 228 💬 |
924 |
Radiation: fluorine f 18 clofarabine |
Clofarabine |
[1] D03546 D03546 💬 |
POLA1 [3] POLA1, POLA2, RRM1 💬 |
DNA replication [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
040 [4] 40, 46, 49, 96 💬 |
925 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 [9] 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
926 |
Ranolazine |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
002 [6] 2 , 58, 86, 96, 113, 114 💬 |
927 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
928 |
Raptiva |
- |
- |
- |
- |
011 [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
929 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 [7] 11, 13, 46, 53, 61, 95, 96 💬 |
930 |
Rbatg |
- |
- |
- |
- |
051 [2] 51, 96 💬 |
931 |
Rctb-401 |
- |
- |
- |
- |
096 [1] 96 💬 |
932 |
Received hormone maintenance therapy |
- |
- |
- |
- |
096 [1] 96 💬 |
933 |
Recombinant growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 96 💬 |
934 |
Recombinant human insulin-like growth factor |
Insulin human |
[2] D00085 D00085, D03230 D03230 💬 |
INSR [1] INSR 💬 |
AMPK signaling pathway [22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway |
096 [1] 96 💬 |
935 |
Recombinant human interleukin-11 (rhil-11) |
Oprelvekin |
[1] D05266 D05266 💬 |
IL11RA [1] IL11RA 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
096 [1] 96 💬 |
936 |
Remestemcel-l |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [2] 96, 97 💬 |
937 |
Remicade |
- |
- |
- |
- |
040 [9] 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
938 |
Remicade (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
939 |
Remicade 100 mg |
- |
- |
- |
- |
056 [2] 56, 96 💬 |
940 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
941 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
942 |
Remsima |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
943 |
Remsima (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
944 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
945 |
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
946 |
Remsima and inflectra |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
947 |
Remsina |
- |
- |
- |
- |
096 [1] 96 💬 |
948 |
Rhamnose |
Rhamnose |
- |
- |
- |
096 [1] 96 💬 |
949 |
Rhb-104 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
950 |
Rhgh |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
076 [4] 76, 78, 96, 193 💬 |
951 |
Rhigf (increlex) |
- |
- |
- |
- |
096 [1] 96 💬 |
952 |
Rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
013 [4] 13, 46, 56, 96 💬 |
953 |
Rhumab to il-17a (igg1-k-class) rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
096 [1] 96 💬 |
954 |
Ribavirin |
Ribavirin |
[1] D00423 D00423 💬 |
- |
- |
002 [2] 2 , 96 💬 |
955 |
Riboflavin |
Riboflavin |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 [8] 13, 38, 46, 96, 97, 162, 168, 265 💬 |
956 |
Riboflavin sodium phosphate injection |
Phosphate ion |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
096 [1] 96 💬 |
957 |
Riboflavin supplementation |
Riboflavin |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
096 [1] 96 💬 |
958 |
Rifabutin |
Rifabutin |
[1] D00424 D00424 💬 |
- |
- |
096 [1] 96 💬 |
959 |
Rifabutin, clarithromycin, and clofazimine |
Clarithromycin |
[3] D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 [1] 96 💬 |
960 |
Rifaximin |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
006 [6] 6 , 65, 96, 97, 99, 296 💬 |
961 |
Rifaximin delayed release (dr) |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
962 |
Rifaximin delayed release 400 mg film coated tablet |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
963 |
Rifaximin delayed release tablets |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
964 |
Rifaximin eir |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
965 |
Rifaximin+omeprazole+miralax |
Omeprazole |
[5] D00455 D00455, D01207 D01207, D02554 D02554, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [1] 96 💬 |
966 |
Rifaximin-eir |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
967 |
Rifaximina |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
968 |
Risankizumab |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [4] 37, 96, 97, 271 💬 |
969 |
Risankizumab 10 mg/ml |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
970 |
Risankizumab 180 mg sc |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
971 |
Risankizumab 600 mg iv |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
972 |
Risankizumab 90 mg/ml |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
973 |
Risankizumab iv |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
974 |
Risankizumab sc |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
975 |
Risedronate |
Risedronic acid |
[3] D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [6] 46, 50, 66, 96, 113, 274 💬 |
976 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
977 |
Rizankisumab |
- |
- |
- |
- |
096 [1] 96 💬 |
978 |
Rizankizumab |
- |
- |
- |
- |
096 [1] 96 💬 |
979 |
Ro 549-0261/f04-02 |
- |
- |
- |
- |
096 [1] 96 💬 |
980 |
Ro 549-0261/f08-02 |
- |
- |
- |
- |
096 [1] 96 💬 |
981 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
982 |
Rosuvastatin 10 mg |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 [1] 96 💬 |
983 |
Routine treatment of cd |
- |
- |
- |
- |
096 [1] 96 💬 |
984 |
Rpc0163 |
- |
- |
- |
- |
096 [1] 96 💬 |
985 |
Rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
986 |
Rpc1063 (equivalent to ozanimod |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [1] 96 💬 |
987 |
Rpc1063 (equivalent to ozanimod hcl) |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [1] 96 💬 |
988 |
Rr110 (tamibarotene) |
Tamibarotene |
[1] D01418 D01418 💬 |
RARA [1] RARA 💬 |
Acute myeloid leukemia [5] Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
096 [1] 96 💬 |
989 |
Rvg 05565 |
- |
- |
- |
- |
096 [1] 96 💬 |
990 |
Rvg 07151 |
- |
- |
- |
- |
096 [1] 96 💬 |
991 |
S38 |
- |
- |
- |
- |
096 [1] 96 💬 |
992 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 [3] 96, 97, 225 💬 |
993 |
Salofalk |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
994 |
Salofalk 500 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
995 |
Sandostatine |
- |
- |
- |
- |
096 [1] 96 💬 |
996 |
Sargramostim |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 [7] 6 , 28, 60, 62, 96, 229, 285 💬 |
997 |
Sargramostim (leukine) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 [1] 96 💬 |
998 |
Sb5 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
999 |
Sc12267 |
SC12267 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1000 |
Sc12267 (4sc-101) |
SC12267 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1001 |
Search for exocrine pancreatic insufficiency at week 0 and 12 |
- |
- |
- |
- |
096 [1] 96 💬 |
1002 |
Selective immunosuppressive agents |
- |
- |
- |
- |
096 [1] 96 💬 |
1003 |
Semapimod |
Semapimod |
- |
- |
- |
096 [1] 96 💬 |
1004 |
Serum albumine 5% |
- |
- |
- |
- |
096 [1] 96 💬 |
1005 |
Serum bovine immunoglobulin |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1006 |
Serum physiologique 0.9 % |
- |
- |
- |
- |
096 [1] 96 💬 |
1007 |
Shingrix |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1008 |
Shp647 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1009 |
Shr0302 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1010 |
Sibofimloc |
Sibofimloc |
[1] D11825 D11825 💬 |
- |
- |
096 [1] 96 💬 |
1011 |
Simethicone |
Simethicone |
[1] D05841 D05841 💬 |
- |
- |
013 [2] 13, 96 💬 |
1012 |
Sivelestat |
Sivelestat |
[1] D03788 D03788 💬 |
ELANE [1] ELANE 💬 |
Neutrophil extracellular trap formation [3] Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 [3] 13, 85, 96 💬 |
1013 |
Smoflipid |
- |
- |
- |
- |
096 [1] 96 💬 |
1014 |
Smoking cigarettes |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1015 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 [2] 96, 97 💬 |
1016 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1017 |
Solid food-based intervention |
- |
- |
- |
- |
096 [1] 96 💬 |
1018 |
Somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [16] 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
1019 |
Somatropin [rdna origin] for injection |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
046 [2] 46, 96 💬 |
1020 |
Somatropin(rhgh) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
096 [1] 96 💬 |
1021 |
Sonovue |
- |
- |
- |
- |
096 [1] 96 💬 |
1022 |
Soy protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1023 |
Soya bean oil |
Bean |
- |
- |
- |
096 [1] 96 💬 |
1024 |
Spesolilmab |
- |
- |
- |
- |
096 [1] 96 💬 |
1025 |
Spesolimab |
Spesolimab |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
1026 |
St10 |
- |
- |
- |
- |
096 [1] 96 💬 |
1027 |
St10-021 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1028 |
Sta-5326 |
- |
- |
- |
- |
065 [2] 65, 96 💬 |
1029 |
Sta-5326 mesylate |
- |
- |
- |
- |
096 [1] 96 💬 |
1030 |
Sta-6838, sta-5326 m, s38 |
- |
- |
- |
- |
096 [1] 96 💬 |
1031 |
Stable isotope infusions |
- |
- |
- |
- |
096 [1] 96 💬 |
1032 |
Standard 2 hours-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1033 |
Standard step-up care |
- |
- |
- |
- |
096 [1] 96 💬 |
1034 |
Start adalimumab in monotherapy |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
1035 |
Stelara |
- |
- |
- |
- |
049 [6] 49, 56, 96, 97, 269, 271 💬 |
1036 |
Stelara 130 mg concentrate for solution for infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
1037 |
Stelara 90 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 [1] 96 💬 |
1038 |
Stelara, remicade, entyvio, humira, remsima, flixabi, inflectra |
- |
- |
- |
- |
096 [1] 96 💬 |
1039 |
Stelara® |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
1040 |
Stem cells |
- |
- |
- |
- |
002 [4] 2 , 4 , 96, 113 💬 |
1041 |
Step-up |
- |
- |
- |
- |
096 [1] 96 💬 |
1042 |
Steroids |
- |
- |
- |
- |
046 [7] 46, 50, 51, 63, 66, 96, 97 💬 |
1043 |
Stromal vascular fraction (svf) |
- |
- |
- |
- |
096 [1] 96 💬 |
1044 |
Sub20016 |
- |
- |
- |
- |
096 [1] 96 💬 |
1045 |
Sucrose |
Sucrose |
[1] D00025 D00025 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
1046 |
Sugar extract |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1047 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
1048 |
Sulfur hexafluoride |
Sulfur hexafluoride |
[1] D05962 D05962 💬 |
- |
- |
096 [1] 96 💬 |
1049 |
Sulphur hexafluoride |
Sulfur hexafluoride |
[1] D05962 D05962 💬 |
- |
- |
096 [1] 96 💬 |
1050 |
Suspension containing 250 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1051 |
Suspension containing 250 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1052 |
Suspension containing 2500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1053 |
Suspension containing 2500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1054 |
Suspension containing 7500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1055 |
Suspension of 7500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1056 |
Suspension of adipose derived autologous adult stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
1057 |
Synbiotic (synergy i / b.longum) |
- |
- |
- |
- |
096 [1] 96 💬 |
1058 |
T2 |
- |
- |
- |
- |
096 [1] 96 💬 |
1059 |
Ta-650 |
- |
- |
- |
- |
037 [4] 37, 56, 96, 97 💬 |
1060 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1061 |
Tak-018 |
- |
- |
- |
- |
096 [1] 96 💬 |
1062 |
Tamibarotene |
Tamibarotene |
[1] D01418 D01418 💬 |
RARA [1] RARA 💬 |
Acute myeloid leukemia [5] Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
026 [2] 26, 96 💬 |
1063 |
Tasty&healthy intervention group |
- |
- |
- |
- |
096 [1] 96 💬 |
1064 |
Tbc |
- |
- |
- |
- |
085 [3] 85, 94, 96 💬 |
1065 |
Td-1473 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1066 |
Teduglutide |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1067 |
Teduglutide (alx-0600) |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1068 |
Teduglutide 0.05 |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1069 |
Teduglutide 0.05 dose |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1070 |
Teduglutide 0.1 mg dose |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1071 |
Teduglutide 0.2 mg |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
1072 |
Tetomilast |
Tetomilast |
- |
- |
- |
096 [2] 96, 97 💬 |
1073 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
1074 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
1075 |
Thalidomide pharmion |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [3] 85, 96, 97 💬 |
1076 |
Thc |
- |
- |
- |
- |
008 [4] 8 , 13, 46, 96 💬 |
1077 |
Thc 5mg/ml and cbs 50mg/ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1078 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 [1] 96 💬 |
1079 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 [1] 96 💬 |
1080 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 [1] 96 💬 |
1081 |
Thetanix |
- |
- |
- |
- |
096 [1] 96 💬 |
1082 |
Thiopurine |
- |
- |
- |
- |
096 [1] 96 💬 |
1083 |
Thiotepa |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
013 [11] 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
1084 |
Threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
086 [3] 86, 96, 97 💬 |
1085 |
Thrx-139060 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1086 |
Thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
036 [6] 36, 51, 60, 65, 96, 326 💬 |
1087 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [5] 13, 36, 51, 60, 96 💬 |
1088 |
Ticilimumab |
Tremelimumab |
[1] D06657 D06657 💬 |
CTLA4 [1] CTLA4 💬 |
Autoimmune thyroid disease [4] Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway |
096 [1] 96 💬 |
1089 |
Time and attention |
- |
- |
- |
- |
096 [1] 96 💬 |
1090 |
Time and attention + active fructooligosaccharide supplementation |
- |
- |
- |
- |
096 [1] 96 💬 |
1091 |
Tnf kinoid |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1092 |
Tnf-alpha antagonists |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
1093 |
Tnf-k |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1094 |
Tnf-kinoid |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1095 |
Tnfa kinoid |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1096 |
Tnfa-kinoid |
- |
- |
- |
- |
096 [1] 96 💬 |
1097 |
To be determined |
- |
- |
- |
- |
096 [1] 96 💬 |
1098 |
To be requested |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1099 |
Tofacitinib |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 [12] 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
1100 |
Tofacitinib (cp-690,550) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
096 [1] 96 💬 |
1101 |
Tolerogenic dendritic cells |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1102 |
Top-down |
- |
- |
- |
- |
096 [1] 96 💬 |
1103 |
Tr004 (treg immunotherapy) |
- |
- |
- |
- |
096 [1] 96 💬 |
1104 |
Treatment with adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
1105 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
1106 |
Trichuris suis eggs |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1107 |
Trichuris suis ova |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
1108 |
Trichuris suis ova (tso) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1109 |
Trichuris trichiura eggs |
- |
- |
- |
- |
096 [1] 96 💬 |
1110 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 [8] 46, 66, 67, 96, 162, 222, 224, 271 💬 |
1111 |
Tripterygium glycosides |
Tripterygium wilfordii whole |
- |
- |
- |
096 [1] 96 💬 |
1112 |
Tris |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
096 [2] 96, 97 💬 |
1113 |
Trk-170 |
- |
- |
- |
- |
096 [1] 96 💬 |
1114 |
Tso 250 |
- |
- |
- |
- |
096 [1] 96 💬 |
1115 |
Tso 2500 |
- |
- |
- |
- |
096 [1] 96 💬 |
1116 |
Tso 7500 |
- |
- |
- |
- |
096 [1] 96 💬 |
1117 |
Tu-100 |
TU-100 |
- |
- |
- |
096 [1] 96 💬 |
1118 |
Tv-5600 |
- |
- |
- |
- |
008 [3] 8 , 13, 96 💬 |
1119 |
Uc-mscs |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
046 [2] 46, 96 💬 |
1120 |
Ultrasound microbubble contrast agent |
- |
- |
- |
- |
096 [1] 96 💬 |
1121 |
Undetermined |
- |
- |
- |
- |
096 [1] 96 💬 |
1122 |
Upadacitinib |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 [7] 40, 41, 46, 49, 96, 97, 271 💬 |
1123 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
006 [8] 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
1124 |
Ursofalk |
- |
- |
- |
- |
093 [4] 93, 94, 96, 97 💬 |
1125 |
Ursofalk® 250 mg tabletten. |
- |
- |
- |
- |
096 [1] 96 💬 |
1126 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
1127 |
Ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
1128 |
Ustekinumab (6 mg/kg) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1129 |
Ustekinumab (90 mg) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1130 |
Ustekinumab 130 mg iv |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1131 |
Ustekinumab 1mg/kg (ip) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1132 |
Ustekinumab 3 mg/kg (ip) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1133 |
Ustekinumab 4.5 mg/kg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1134 |
Ustekinumab 6 mg/kg (ip) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1135 |
Ustekinumab 90 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [4] 49, 50, 93, 96 💬 |
1136 |
Ustekinumab 90 mg (sc) group 1 |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1137 |
Ustekinumab 90 mg (sc) group 2 |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1138 |
Ustekinumab 90 mg sc q12w |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1139 |
Ustekinumab 90 mg sc q8w |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1140 |
Ustekinumab approximately 6 mg/kg (iv) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1141 |
Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1142 |
Ustekinumab iv - responder - ustekinumab 90mg sc (mp) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [1] 96 💬 |
1143 |
Ustekinumab iv infusion |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [2] 96, 97 💬 |
1144 |
Ustekinumab sc injection |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [2] 96, 97 💬 |
1145 |
Usual current care |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1146 |
Uttr1147a |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1147 |
Uttr1147a, il22-fc, il-22fc |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1148 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1149 |
Uvadex |
- |
- |
- |
- |
046 [2] 46, 96 💬 |
1150 |
Uvadex and uvar xts photopheresis system |
- |
- |
- |
- |
096 [1] 96 💬 |
1151 |
V565 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1152 |
Vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
046 [7] 46, 70, 94, 96, 97, 296, 299 💬 |
1153 |
Vedolizumab |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
1154 |
Vedolizumab (genetical recombination) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
1155 |
Vedolizumab 300 mg injection [entyvio] |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
1156 |
Vedolizumab intravenous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1157 |
Vedolizumab iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
1158 |
Vedolizumab iv (entyvio™) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
1159 |
Vedolizumab iv 300 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
1160 |
Vedolizumab sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1161 |
Vedolizumab sc 108 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1162 |
Vedolizumab subcutaneous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1163 |
Vedolizumab-800cw |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
1164 |
Vehice control |
- |
- |
- |
- |
096 [1] 96 💬 |
1165 |
Verapamil |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [3] 96, 140, 167 💬 |
1166 |
Viagra |
- |
- |
- |
- |
086 [3] 86, 96, 225 💬 |
1167 |
Vialebex |
- |
- |
- |
- |
096 [1] 96 💬 |
1168 |
Vialebex 200mg |
- |
- |
- |
- |
096 [1] 96 💬 |
1169 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 [5] 13, 46, 94, 96, 97 💬 |
1170 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 [4] 13, 94, 96, 97 💬 |
1171 |
Vigantol |
- |
- |
- |
- |
013 [4] 13, 65, 96, 97 💬 |
1172 |
Vigantol oel |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1173 |
Vigantol oel tm |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1174 |
Visilizumab |
Visilizumab |
[1] D06314 D06314 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
1175 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1176 |
Vitamin d drops |
Vitamin D |
- |
- |
- |
096 [2] 96, 97 💬 |
1177 |
Vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [11] 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1178 |
Vitamin d3 3000 ui daily |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
1179 |
Vitamin d3 4000 ui daily |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
1180 |
Vitamin d3 800 ui/day then 800 ui/day |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
1181 |
Vitamin d3: 3000 or 4000 ui/day then 2,000 ui/day |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
1182 |
Vitamin e |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
002 [11] 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1183 |
Vitamin e 800iu |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
096 [2] 96, 97 💬 |
1184 |
Vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [5] 13, 46, 96, 97, 299 💬 |
1185 |
Vitamin k 10 mg |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
096 [2] 96, 97 💬 |
1186 |
Vitamin k1 |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
096 [1] 96 💬 |
1187 |
Vorinostat |
Vorinostat |
[1] D06320 D06320 💬 |
HDAC1 [11] HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis |
019 [3] 19, 75, 96 💬 |
1188 |
Vsl#3 |
- |
- |
- |
- |
096 [3] 96, 97, 291 💬 |
1189 |
Vsl#3 (original de simone formulation) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1190 |
Vsl#3® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1191 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1192 |
Warfarin 10 mg |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 [2] 96, 97 💬 |
1193 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1194 |
Wellbutrin (bupropion) |
Bupropion |
[3] D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
096 [1] 96 💬 |
1195 |
Wfi |
- |
- |
- |
- |
096 [1] 96 💬 |
1196 |
Whey protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1197 |
Wmt |
- |
- |
- |
- |
096 [1] 96 💬 |
1198 |
Xanthohumol |
Xanthohumol |
- |
- |
- |
096 [1] 96 💬 |
1199 |
Z-206 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1200 |
Zessly |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1201 |
Zoledronic acid |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [9] 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |
1202 |
Zp1848 |
- |
- |
- |
- |
096 [1] 96 💬 |
1203 |
Ácido gadobénico |
- |
- |
- |
- |
096 [1] 96 💬 |